SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,606.00    20.00 (0.44%)
Bid:
4,608.00
Ask:
4,610.00
Spread: 2.00 (0.043%)
Market Cap: £16.79b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Transaction in Own Shares

14 Jan 2019 07:09

RNS Number : 9802M
Coca-Cola HBC AG
14 January 2019
 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG

Transaction in own shares

 

Zug, Switzerland - 14 January 2019 - Coca-Cola HBC AG ("Company") announces that it purchased the following number of its ordinary shares of 6.70 CHF each ("ordinary shares") on the London Stock Exchange through Credit Suisse Securities (Europe) Limited ("Credit Suisse") as part of its share purchase programme announced on Monday 3 December 2018:

 

Date of transaction

11 January 2019

Number of shares repurchased

70,000

Average price paid per share

2516.22 pence

Lowest price paid per share

2499.00 pence

Highest price paid per share

2552.00 pence

Broker

Credit Suisse

 

The repurchased ordinary shares will be either cancelled upon receiving approval from the Company's shareholders and subsequent implementation of a capital decrease or be used to meet the requirements of the Company's employee incentive scheme. Until such approval is obtained or the shares are used to meet such requirements, the repurchased ordinary shares will be held in treasury.

 

As at 14 January 2019, the Company's issued share capital consisted of 371,827,229 ordinary shares, of which 1,321,938 ordinary shares are held by Coca-Cola HBC AG (including the repurchased shares) and 3,430,135 ordinary shares are held by its subsidiary, Coca-Cola HBC Services MEPE, in treasury. Therefore the total number of voting rights in the Company is 367,075,156 which may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Since announcing the share purchase programme on Monday 3 December 2018, the Company has purchased 1,307,013 of its ordinary shares.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), a full breakdown of the transactions made by Credit Suisse on behalf of the Company as part of the share purchase programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/9802M_1-2019-1-14.pdf

 

 

Enquiries

Coca‑Cola HBC Group

Maria Livaniou

Head of shareowner services

 

Tel: +30 210 6183 106

 maria.livaniou@cchellenic.com

 

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with an annual sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 600 million people. Coca-Cola HBC offers a diverse range of primarily non-alcoholic ready-to-drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC has been listed in the Dow Jones Sustainability Indices since 2008, and ranked among the top beverage companies in the Global and European indices for the past four years. Coca-Cola HBC is also included in the FTSE4Good Index, rated "AAA" on the MSCI ESG index, rated "A" for Climate and Water by CDP and listed on the Sustainalytics and Vigeo rankings.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

 

 

Important notice relating to Credit Suisse

Credit Suisse, which is regulated by the Financial Conduct Authority in the UK, is acting exclusively for the Company and no one else in connection with the matters set out in this announcement and will not be responsible to any person other than the Company for providing the protections afforded to clients of Credit Suisse, nor for providing advice in relation to the content of this announcement or any matter referred to herein. Neither Credit Suisse nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Credit Suisse in connection with this announcement, any statement contained herein or otherwise.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSUSRBRKNAAARR
Date   Source Headline
11th Jul 20233:53 pmRNSNotice of Results
7th Jul 20237:00 amRNSTRADING UPDATE
3rd Jul 20239:12 amRNSDirector/PDMR Shareholding
3rd Jul 20238:32 amRNSIssue of equity and total voting rights
23rd Jun 20234:04 pmRNSDirector/PDMR Shareholding
21st Jun 202311:05 amRNSDirector/PDMR Shareholding
21st Jun 202310:46 amRNSDirector/PDMR Shareholding
19th Jun 20233:06 pmRNSDirector/PDMR Shareholding
19th Jun 20237:00 amRNSCCH to acquire Finlandia Vodka from Brown-Forman
1st Jun 202310:07 amRNSIssue of equity and total voting rights
25th May 20237:00 amRNSCoca-Cola HBC Investor Day
18th May 20232:50 pmRNSDirector/PDMR Shareholding
18th May 20232:46 pmRNSDirector/PDMR Shareholding
17th May 20233:44 pmRNSCCH - Board Committees Composition
17th May 20233:37 pmRNSResult of AGM
4th May 20232:43 pmRNSAthens Exchange trading date of ordinary shares
3rd May 20237:00 amRNSStrategic progress driving strong revenue growth
2nd May 202311:23 amRNSBlock listing Interim Review
2nd May 202310:38 amRNSIssue of equity and total voting rights
24th Apr 20232:03 pmRNSNotice of Results-NEW TIME for the analysts call
18th Apr 20232:46 pmRNSDirector/PDMR Shareholding
13th Apr 20238:41 amRNSNotice of AGM
3rd Apr 20233:14 pmRNSNotice of Results
3rd Apr 20232:52 pmRNSIssue of equity and total voting rights
31st Mar 20232:54 pmRNSDirector/PDMR Shareholding
31st Mar 202312:30 pmRNSDirector/PDMR Shareholding
31st Mar 202312:22 pmRNSDirector/PDMR Shareholding
31st Mar 20239:11 amRNSDirector/PDMR Shareholding
31st Mar 20238:52 amRNSDirector/PDMR Shareholding
24th Mar 20231:48 pmRNSDirector/PDMR Shareholding
23rd Mar 20231:10 pmRNSDirector/PDMR Shareholding
21st Mar 20239:48 amRNSDirector/PDMR Shareholding
21st Mar 20239:20 amRNSDirector/PDMR Shareholding
20th Mar 20234:11 pmRNSAnnual Financial Report
17th Mar 20232:39 pmRNSDirector/PDMR Shareholding
15th Mar 20232:38 pmRNSDirector/PDMR Shareholding
8th Mar 202310:46 amRNSHolding(s) in Company
7th Mar 202311:56 amRNSHolding(s) in Company
6th Mar 20233:29 pmRNSDirector/PDMR Shareholding
3rd Mar 20238:00 amRNSDirector/PDMR Shareholding
1st Mar 20232:11 pmRNSIssue of equity and total voting rights
28th Feb 20238:09 amRNSDirector/PDMR Shareholding
23rd Feb 20239:21 amRNSDirector/PDMR Shareholding
22nd Feb 20233:54 pmRNSDirector/PDMR Shareholding
22nd Feb 20233:43 pmRNSDirector/PDMR Shareholding
20th Feb 20232:46 pmRNSDirector/PDMR Shareholding
20th Feb 20232:13 pmRNSDirector/PDMR Shareholding
16th Feb 202311:28 amRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSStrong execution drives another year of growth
1st Feb 20231:50 pmRNSIssue of equity and total voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.